<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39462879</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1369-7625</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Health expectations : an international journal of public participation in health care and health policy</Title><ISOAbbreviation>Health Expect</ISOAbbreviation></Journal><ArticleTitle>Personalised Health Behaviour Support Programme in Adults With Post-COVID Syndrome: A Randomised, Controlled Pilot Feasibility Trial.</ArticleTitle><Pagination><StartPage>e70079</StartPage><MedlinePgn>e70079</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70079</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/hex.70079</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We investigated whether a novel 8-week personalised health behaviour support programme, focusing on the stability of symptoms and strategies to improve activities of daily living, was feasible and acceptable in adults with post-COVID syndrome.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this randomised, controlled, pilot feasibility trial, 32 adults with post-COVID syndrome (continued symptoms for ≥ 12 weeks) were randomised 1:1 to receive personalised health behaviour support (self-reported physical activity and symptom diaries, plus seven one-to-one remotely delivered personalised self-management support sessions), once weekly for 8-weeks, or usual care (referral to online 'your COVID-19 recovery' programme). The primary outcome was the feasibility of recruiting and randomising adults with post-COVID syndrome. The secondary outcomes were to assess the acceptability and safety of the intervention and various outcome measures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 48 adults who expressed interest in the study, 32 (67%) were eligible and completed the baseline assessment. All 32 adults were willing to be randomised to either the personalised health behaviour support programme (n = 17) or usual care (n = 15) and 27 (age: 45 ± 12 years) adults completed follow-up at 9 weeks. The intervention was deemed feasible, with high adherence (92% and 94% completion rates for the physical activity and symptom diaries, respectively) and excellent acceptability rates (94% 'liked the intervention a lot'). The intervention was deemed safe, with no symptom exacerbations reported.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An 8-week personalised health behaviour support programme was feasible for adults with post-COVID syndrome, with good adherence and acceptability rates. Early pilot data from this small sample also suggests meaningful improvements in physical activity, fatigue and respiratory symptoms.</AbstractText><AbstractText Label="PATIENT OR PUBLIC CONTRIBUTION" NlmCategory="UNASSIGNED">People living with post-COVID syndrome were involved from the outset with the study design, review of study documentation and interpretation of the data following completion. Furthermore, several participants have supported the local dissemination of findings following the completion of the study.</AbstractText><CopyrightInformation>© 2024 The Author(s). Health Expectations published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7759-444X</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation and Sport Sciences, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, South West, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sport and Exercise Sciences, Faculty of Social Sciences and Health, Durham University, Durham, North East, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owen</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation and Sport Sciences, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, South West, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Niekerk</LastName><ForeName>Kristen Shirley</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation and Sport Sciences, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, South West, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saynor</LastName><ForeName>Zoe L</ForeName><Initials>ZL</Initials><AffiliationInfo><Affiliation>School of Health Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, South West, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory, University Hospital Southampton NHS Foundation Trust, Southampton, South West, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Southampton Biomedical Research Centre, Southampton Centre for Biomedical Research, Southampton, South West, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Funding for this study was given by Bournemouth University QR Acorn funding.</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Expect</MedlineTA><NlmUniqueID>9815926</NlmUniqueID><ISSNLinking>1369-6513</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="Y">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015438" MajorTopicYN="Y">Health Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073278" MajorTopicYN="N">Self-Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">behaviour change</Keyword><Keyword MajorTopicYN="N">physical activity</Keyword><Keyword MajorTopicYN="N">post‐COVID syndrome</Keyword><Keyword MajorTopicYN="N">supported self‐management</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39462879</ArticleId><ArticleId IdType="doi">10.1111/hex.70079</ArticleId><ArticleId IdType="pmc">PMC11513405</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>OfNS . Self‐Reported Coronavirus (COVID‐19) Infections and Associated Symptoms, England and Scotland: November 2023 to March 2024 ONS Website 2024.</Citation></Reference><Reference><Citation>Soriano J. B., Murthy S., Marshall J. C., Relan P., and Diaz J. V., “A Clinical Case Definition of Post‐COVID‐19 Condition by a Delphi Consensus,” Lancet infectious diseases 22, no. 4 (2022): e102–e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys H., Kilby L., Kudiersky N., and Copeland R. Long Covid and the Role of Physical Activity: A Qualitative Study (preprint). 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948149</ArticleId><ArticleId IdType="pubmed">33692189</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelley J., Hudson J., Mackintosh K. A., et al., “‘I Live a Kind of Shadow Life’: Individual Experiences of COVID‐19 Recovery and the Impact on Physical Activity Levels,” International Journal of Environmental Research and Public Health 18, no. 21 (2021): 11417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8583577</ArticleId><ArticleId IdType="pubmed">34769934</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares‐Zapatero D., Chalon P., Kohn L., et al., “Pathophysiology and Mechanism of Long Covid: A Comprehensive Review,” Annals of Medicine 54, no. 1 (2022): 1473–1487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., Townsend L., Savinelli S., and Mallon P. W. G., “Long Covid: Clinical Characteristics, Proposed Pathogenesis and Potential Therapeutic Targets,” Frontiers in Molecular Biosciences 10 (2023): 1157651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10171433</ArticleId><ArticleId IdType="pubmed">37179568</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A. D. and VanElzakker M. B., “Long Covid or Post‐Acute Sequelae of COVID‐19 (Pasc): An Overview of Biological Factors That May Contribute to Persistent Symptoms,” Frontiers in Microbiology 12 (2021): 698169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S. and Merad M., “Pathological Sequelae of Long‐Haul Covid,” Nature Immunology 23, no. 2 (2022): 194–202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J. W. Y., Su Q., et al., “Gut Microbiota Dynamics in a Prospective Cohort of Patients With Post‐Acute COVID‐19 Syndrome,” Gut 71, no. 3 (2022): 544–552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z. A., Gomez C. R., Connors T. J., Henrich T. J., and Reeves W. B., “Pathogenic Mechanisms of Post‐Acute Sequelae of SARS‐CoV‐2 Infection (Pasc),” Elife 12 (2023): e86002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A. J., Sykes R., McIntosh A., et al., “A Multisystem, Cardio‐Renal Investigation of Post‐COVID‐19 Illness,” Nature Medicine 28, no. 6 (2022): 1303–1313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9205780</ArticleId><ArticleId IdType="pubmed">35606551</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I., Schulze A., Evers G., et al., “Persistent Capillary Rarefication in Long Covid Syndrome,” Angiogenesis 26, no. 1 (2023): 53–61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al., “Post‐Acute COVID‐19 Syndrome,” Nature Medicine 27, no. 4 (2021): 601–615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira M. R., Hoffman M., Jones A. W., Holland A. E., and Borghi‐Silva A., “Effect of Pulmonary Rehabilitation on Exercise Capacity, Dyspnea, Fatigue and Peripheral Muscle Strength in Patients With Post‐COVID‐19 Syndrome: A Systematic Review and Meta‐Analysis,” Archives of Physical Medicine and Rehabilitation 105 (2024): 1559–1570.</Citation><ArticleIdList><ArticleId IdType="pubmed">38311096</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes E., Gerlis C., Chaplin E., Gardiner N., and Singh S. J., “Early Experiences of Rehabilitation for Individuals Post‐Covid to Improve Fatigue, Breathlessness Exercise Capacity and Cognition–A Cohort Study,” Chronic Respiratory Disease 18 (2021): 14799731211015691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114752</ArticleId><ArticleId IdType="pubmed">33957805</ArticleId></ArticleIdList></Reference><Reference><Citation>McNarry M. A., Berg R. M. G., Shelley J., et al., “Inspiratory Muscle Training Enhances Recovery Post‐COVID‐19: A Randomised Controlled Trial,” European Respiratory Journal 60, no. 4 (2022): 2103101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900538</ArticleId><ArticleId IdType="pubmed">35236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker M., Sawant H. B., Flannery T., et al., “Effect of Using a Structured Pacing Protocol on Post‐Exertional Symptom Exacerbation and Health Status in a Longitudinal Cohort With the Post‐COVID‐19 Syndrome,” Journal of Medical Virology 95, no. 1 (2023): e28373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878088</ArticleId><ArticleId IdType="pubmed">36461167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A., Lacombe V., Ravaiau C., et al., “The Relevance of Pacing Strategies in Managing Symptoms of Post‐COVID‐19 Syndrome,” Journal of Translational Medicine 21, no. 1 (2023): 375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10248991</ArticleId><ArticleId IdType="pubmed">37291581</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor G., Sandhu H., Bruce J., et al, “Clinical Effectiveness of an Online Supervised Group Physical and Mental Health Rehabilitation Programme for Adults With Post‐COVID‐19 Condition (Regain Study): Multicentre Randomised Controlled Trial,” BMJ 384 (2024): e076506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11134408</ArticleId><ArticleId IdType="pubmed">38325873</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMars J., Brown D. A., Angelidis I., et al., “What Is Safe Long Covid Rehabilitation?,” Journal of Occupational Rehabilitation 33, no. 2 (2023): 227–230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9628454</ArticleId><ArticleId IdType="pubmed">36315323</ArticleId></ArticleIdList></Reference><Reference><Citation>Blatch‐Jones A. J., Pek W., Kirkpatrick E., and Ashton‐Key M., “Role of Feasibility and Pilot Studies in Randomised Controlled Trials: A Cross‐Sectional Study,” BMJ open 8, no. 9 (2018): e022233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6169762</ArticleId><ArticleId IdType="pubmed">30257847</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos‐Reed S. N., Weatherald J., and Wrightson J. G., “Chronic Fatigue and Postexertional Malaise in People Living With Long Covid: An Observational Study,” Physical therapy 102, no. 4 (2022): pzac005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunnquist M., Lazarus S., and Jason L. A., “The Development of a Short Form of the DePaul Symptom Questionnaire,” Rehabilitation psychology 64, no. 4 (2019): 453–462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6803042</ArticleId><ArticleId IdType="pubmed">31318234</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller W. R. and Rollnick S., “Talking Oneself Into Change: Motivational Interviewing, Stages of Change, and Therapeutic Process,” Journal of Cognitive psychotherapy 18, no. 4 (2004): 299–308.</Citation></Reference><Reference><Citation>Miller W. R. and Rollnick S., Motivational Interviewing: Helping People Change (Guilford Press, 2012).</Citation></Reference><Reference><Citation>Michie S. and Johnston M., Theories and Techniques of Behaviour Change: Developing a Cumulative Science of Behaviour Change (Taylor &amp; Francis, 2012), 1–6.</Citation></Reference><Reference><Citation>Schroé H., Van Dyck D., De Paepe A., et al., “Which Behaviour Change Techniques Are Effective to Promote Physical Activity and Reduce Sedentary Behaviour in Adults: A Factorial Randomized Trial of an e‐and m‐Health Intervention,” International Journal of Behavioral Nutrition and Physical Activity 17 (2020): 127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539442</ArticleId><ArticleId IdType="pubmed">33028335</ArticleId></ArticleIdList></Reference><Reference><Citation>
NIHR
. Living With COVID‐19 ‐ Second Review, 2021, https://evidence.nihr.ac.uk/themedreview/living-With-covid19-second-review/#What.</Citation></Reference><Reference><Citation>Goudsmit E. M., Nijs J., Jason L. A., and Wallman K. E., “Pacing as a Strategy to Improve Energy Management in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Consensus Document,” Disability and Rehabilitation 34, no. 13 (2012): 1140–1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">22181560</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., Paul L., and Wallman K., “Chronic Fatigue Syndrome: An Approach Combining Self‐Management With Graded Exercise to Avoid Exacerbations,” Journal of Rehabilitation Medicine 40, no. 4 (2008): 241–247.</Citation><ArticleIdList><ArticleId IdType="pubmed">18382818</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeckx M., Rabinovich R. A., Demeyer H., et al., “Smartphone‐Based Physical Activity Telecoaching in Chronic Obstructive Pulmonary Disease: Mixed‐Methods Study on Patient Experiences and Lessons for Implementation,” JMIR mHealth and uHealth 6, no. 12 (2018): e9774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6320438</ArticleId><ArticleId IdType="pubmed">30578215</ArticleId></ArticleIdList></Reference><Reference><Citation>Demeyer H., Louvaris Z., Frei A., et al., “Physical Activity Is Increased by a 12‐Week Semiautomated Telecoaching Programme in Patients With COPD: A Multicentre Randomised Controlled Trial,” Thorax 72, no. 5 (2017): 415–423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520265</ArticleId><ArticleId IdType="pubmed">28137918</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich R. A., Louvaris Z., Raste Y., et al., “Validity of Physical Activity Monitors During Daily Life in Patients With COPD,” European Respiratory Journal 42, no. 5 (2013): 1205–1215.</Citation><ArticleIdList><ArticleId IdType="pubmed">23397303</ArticleId></ArticleIdList></Reference><Reference><Citation>Gimeno‐Santos E., Raste Y., Demeyer H., et al., “The Proactive Instruments to Measure Physical Activity in Patients With Chronic Obstructive Pulmonary Disease,” European Respiratory Journal 46, no. 4 (2015): 988–1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4589432</ArticleId><ArticleId IdType="pubmed">26022965</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland A. E., Spruit M. A., Troosters T., et al., “An Official European Respiratory Society/American Thoracic Society Technical Standard: Field Walking Tests in Chronic Respiratory Disease,” European Respiratory Journal 44, no. 6 (2014): 1428–1446.</Citation><ArticleIdList><ArticleId IdType="pubmed">25359355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini A., Crisafulli E., D'Andria M., et al., “Minimum Clinically Important Difference in 30‐s Sit‐To‐Stand Test After Pulmonary Rehabilitation in Subjects With COPD,” Respiratory care 64, no. 10 (2019): 1261–1269.</Citation><ArticleIdList><ArticleId IdType="pubmed">31270178</ArticleId></ArticleIdList></Reference><Reference><Citation>Puhan M. A., Siebeling L., Zoller M., Muggensturm P., and Ter Riet G., “Simple Functional Performance Tests and Mortality in COPD,” European Respiratory Journal 42, no. 4 (2013): 956–963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3787814</ArticleId><ArticleId IdType="pubmed">23520321</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M., Gudex C., Lloyd A., et al., “Development and Preliminary Testing of the New Five‐Level Version of EQ‐5D (Eq‐5D‐5L),” Quality of life research 20 (2011): 1727–1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Smid D. E., Franssen F. M. E., Houben‐Wilke S., et al., “Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis,” Journal of the American Medical Directors Association 18, no. 1 (2017): 53–58.</Citation><ArticleIdList><ArticleId IdType="pubmed">27624705</ArticleId></ArticleIdList></Reference><Reference><Citation>Morriss R., Wearden A., and Mullis R., “Exploring the Validity of the Chalder Fatigue Scale in Chronic Fatigue Syndrome,” Journal of Psychosomatic Research 45, no. 5 (1998): 411–417.</Citation><ArticleIdList><ArticleId IdType="pubmed">9835234</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones P. W., Harding G., Berry P., Wiklund I., Chen W. H., and Kline Leidy N., “Development and First Validation of the COPD Assessment Test,” European Respiratory Journal 34, no. 3 (2009): 648–654.</Citation><ArticleIdList><ArticleId IdType="pubmed">19720809</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall J. C., Paul E. A., Garrod R., Garnham R., Jones P. W., and Wedzicha J. A., “Usefulness of the Medical Research Council (MRC) Dyspnoea Scale as a Measure of Disability in Patients With Chronic Obstructive Pulmonary Disease,” Thorax 54, no. 7 (1999): 581–586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z. S., Phillips N. A., Bédirian V., et al., “The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool for Mild Cognitive Impairment,” Journal of the American Geriatrics Society 53, no. 4 (2005): 695–699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins J., Charles J. M., Edwards M., et al., “Acceptability and Feasibility of Implementing Accelorometry‐Based Activity Monitors and a Linked Web Portal in an Exercise Referral Scheme: Feasibility Randomized Controlled Trial,” Journal of medical Internet research 21, no. 3 (2019): e12374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6460312</ArticleId><ArticleId IdType="pubmed">30924791</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz K. F. and Grimes D. A., “Sample Size Slippages in Randomised Trials: Exclusions and the Lost and Wayward,” The Lancet 359, no. 9308 (2002): 781–785.</Citation><ArticleIdList><ArticleId IdType="pubmed">11888606</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization W. H., Clinical Management of COVID‐19: Living Guideline (World Health Organization, 2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35917394</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieur G., Combret Y., Medrinal C., et al., “Energy Conservation Technique Improves Dyspnoea When Patients With Severe Copd Climb Stairs: A Randomised Crossover Study,” Thorax 75, no. 6 (2020): 510–512.</Citation><ArticleIdList><ArticleId IdType="pubmed">32217783</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M. A., Duncan R., Hume E., et al., “Developing Effective Strategies to Optimize Physical Activity and Cardiorespiratory Fitness in the Long Covid Population: The Need for Caution and Objective Assessment,” Progress in Cardiovascular Diseases 83 (2024): 62–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">38460898</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallman K. E., Morton A. R., Goodman C., Grove R., and Guilfoyle A. M., “Randomised Controlled Trial of Graded Exercise in Chronic Fatigue Syndrome,” Medical Journal of Australia 180, no. 9 (2004): 444–448.</Citation><ArticleIdList><ArticleId IdType="pubmed">15115421</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter C., Leggat F., Lowe R., et al., “Effectiveness and Cost‐Effectiveness of a Personalised Self‐Management Intervention for Living With Long Covid: Protocol for the Listen Randomised Controlled Trial,” Trials 24, no. 1 (2023): 75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9890432</ArticleId><ArticleId IdType="pubmed">36726167</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>